U.S. Household Products Stock News

With 30 year and 10 year Treasury yields pushing toward levels not seen in decades, the bond market is quietly rewriting the playbook for investors. Higher long term rates can pressure many stocks, yet they can also reshape the income potential and risk profile of others. This article looks at how that backdrop ties into three U.S. life insurers and annuity providers exposed to these yield moves, and what that could mean for your watchlist. The three stocks covered below are only a starting...

Why Paylocity’s latest earnings and partnerships matter for investors Paylocity Holding (PCTY) has been in focus after reporting fourth quarter and full year 2026 earnings alongside new partnerships that tie its human capital platform more tightly into AI driven recruiting tools. The company’s recent collaboration with HireQuotient and RocketReach links Paylocity’s cloud based HR, payroll and spend management suite to data powered sourcing and screening. This lets customers automate parts of...

StepStone Group (STEP) is back in focus after reporting first quarter results for the period ended June 30, 2026. The company posted higher revenue alongside a wider net loss that may raise fresh questions for investors. See our latest analysis for StepStone Group. Despite the wider loss in the latest quarter, StepStone Group’s share price has risen 10.86% over the past month, although the share price is still down 27.52% year to date and the 1 year total shareholder return is down 16.18%,...

Walmart stock has delivered a strong 142.1% total return over the past five years, while the latest valuation work using a Discounted Cash Flow (DCF) approach suggests the shares trade at a premium to that intrinsic value estimate. Over five years, Walmart has returned 142.1%, which puts recent gains under the spotlight as investors assess how much future cash flow is already reflected in the price. Growth expectations around e-commerce, advertising and automation partnerships such as the...

Eli Lilly stock has delivered a very large 5 year return while valuation checks now give a more mixed read. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside compared with a share price that already embeds high expectations. Eli Lilly has returned about 362.3% over 5 years, which puts extra focus on whether current holders are paying a premium for that track record. Expectations around long term demand for its obesity and diabetes treatments can support...

Earlier this year, DexCom highlighted that expanded insurance reimbursement now gives its continuous glucose monitoring systems access to a large group of type 2 non-insulin diabetes patients, while recent Q2 clinical data and product updates underscored the medical benefits of broader CGM use. This combination of wider coverage and strong evidence base is reshaping expectations for DexCom’s long-term demand profile and business mix, even as competition and pricing uncertainties remain...

Vera Therapeutics, Inc. reported past second quarter 2026 results showing a net loss of US$109.47 million, up from US$76.53 million a year earlier, with basic loss per share from continuing operations widening to US$1.52 from US$1.20. For the first half of 2026, the company’s net loss rose to US$230.51 million from US$128.23 million, highlighting a materially higher cash burn and pressure on per-share results at this stage of its development. Next, we will examine how this widening net loss...

Over the last 7 days, the United States market has remained flat, but it is up 19% over the past year with earnings expected to grow by 17% per annum over the next few years. In this context of steady growth and optimistic projections, identifying high-growth tech stocks involves looking for companies that demonstrate strong innovation and potential for expansion in a dynamic industry landscape.

In the last week, the United States market has stayed flat, yet it has experienced a notable 19% increase over the past year, with earnings expected to grow by 17% annually in the coming years. In this context of steady growth and positive earnings outlooks, identifying undervalued stocks can present opportunities for investors to capitalize on potential market inefficiencies.

Over the last 7 days, the United States market has remained flat, yet it is up 19% over the past year with earnings forecasted to grow by 17% annually. In this environment, growth companies with high insider ownership can be appealing as they often align management's interests with those of shareholders, potentially driving long-term value.

In the last week, the market has stayed flat, but it is up 19% over the past year with earnings expected to grow by 17% annually. For investors seeking opportunities beyond traditional stocks, penny stocks — a term that may seem outdated yet remains relevant — can provide access to smaller or less-established companies with potential for growth. By focusing on those with robust financials and a clear growth trajectory, investors might uncover promising prospects within this niche segment of...

Tariffs on Canadian autos and the threat of wider counter moves are reshaping how vehicles and parts move across the border, and that puts freight routes and rail lines under the spotlight. Investors watching this Canada and U.S. auto trade story may see both pressure and possibility as supply chains adjust. This article walks through three stocks that appear exposed to this news and explains why the market is paying attention now. The three stocks below are just a starting sample, and the...

Virtus Investment Partners has converted the Zevenbergen Growth Fund and Zevenbergen Genea Fund into the actively managed Virtus Zevenbergen Innovative Growth ETF (ZINN) and Virtus Zevenbergen Discovery Growth ETF (ZDIS), expanding its ETF lineup while retaining Zevenbergen Capital Investments’ high-growth equity strategies. This move shifts Zevenbergen’s growth approach into an ETF structure that offers intraday trading, full portfolio transparency, and potential tax efficiencies for...

Why the TETON-PPF milestone matters for United Therapeutics stock United Therapeutics (UTHR) has reached full enrollment in its 754 patient TETON-PPF phase 3 trial of nebulized Tyvaso for progressive pulmonary fibrosis, a key step toward potential label expansion. This milestone gives you a clearer timetable for the next catalyst. Topline data are expected in the second half of 2027, and the company has flagged the study as a basis for a possible supplemental FDA filing. See our latest...

Fresh commentary on CubeSmart (CUBE) has put its dividend profile, growth potential, and exposure to migration trends in focus as investors reassess self storage REITs and look for income opportunities in the sector. See our latest analysis for CubeSmart. CubeSmart’s share price has climbed 16.21% year to date to US$41.14, with a 90 day share price return of 5.60% and a 1 year total shareholder return of 11.53%. This points to gradually improving momentum as investors react to commentary...

Interparfums (IPAR) is back on investors’ radar after affirming a regular quarterly dividend of $0.80 per share, updating its buyback activity, and reporting second quarter earnings alongside full year 2026 guidance. See our latest analysis for Interparfums. Interparfums’ recent dividend affirmation, buyback update, and earnings release come after a period where the share price has risen 30.8% year to date, while the 1 year total shareholder return is 2.3%. Near term momentum has been strong,...

WEBTOON Entertainment Inc. recently reported second-quarter 2026 results showing sales of US$338.47 million and a wider net loss of US$15.25 million, and issued third-quarter guidance for constant-currency revenue growth of 0.7%–3.3% to US$358–US$368 million. Management pointed to softness in Japan and heavier marketing spend alongside progress in AI features and IP adaptations, highlighting a tension between near-term profit pressure and longer-term efforts to deepen engagement and...

In the past quarter, Pelagos Insurance Capital Limited reported second‑quarter 2026 revenue of US$650 million and net income of US$44.4 million, with basic earnings per share from continuing operations of US$0.53. For the first half of 2026 the company moved from a loss to a profit and completed a large-scale buyback that has retired about one‑third of its shares, pointing to an assertive capital return approach. Next, we will examine how Pelagos’s sharp earnings turnaround and extensive...

Highwoods Properties (HIW) recently declared a quarterly dividend totaling US$0.50 per share, with an ex-dividend date of 17 August 2026. This continues a long streak of annual increases but comes as investors assess dividend sustainability. See our latest analysis for Highwoods Properties. The share price of Highwoods Properties has eased in the short term, with a 1-day share price return of 2.70% down and a 30-day share price return of 7.98% down, even after a 90-day share price return of...

Nebius Group stock has delivered a powerful run over the past few years, yet the latest valuation checks suggest the shares are now pricing in a lot of optimism. After such strong gains, investors are weighing rich expectations against what the numbers say about value. Over the past 5 years, Nebius Group has returned about 290%, which puts extra focus on whether current buyers are paying up for that performance. Recent AI cloud contract wins and rapid capacity build out can support high...

Navitas Semiconductor (NVTS) is drawing attention ahead of its planned appearance at Rosenblatt's 6th Annual Technology Summit, The Age of AI. Investors hope to hear more about its AI power chip roadmap. See our latest analysis for Navitas Semiconductor. That interest has come on the back of strong recent momentum in Navitas Semiconductor, with a 7 day share price return of 10.71% and a 30 day share price return of 27.23% at a last close of US$14.58. The year to date share price return of...

In the second quarter of 2026, Intellia Therapeutics reported a net loss of US$106.63 million, with basic loss per share from continuing operations of US$0.80, while its six‑month net loss reached US$202.87 million and basic loss per share was US$1.61, both reflecting reduced losses versus a year earlier. The combination of a slightly higher quarterly net loss but improved loss per share, alongside a smaller half‑year net loss, may influence how investors assess Intellia’s progress in...

In early August 2026, Red Rock Resorts, Inc. reported lower quarterly and half-year revenue and net income versus a year earlier, while its board declared a US$0.26 per Class A share cash dividend for the second quarter, payable on September 30, 2026 to holders of record on September 15, 2026. The combination of softer earnings and a maintained dividend, alongside fresh discounted cash flow analysis pointing to potential undervaluation, raises questions about how Red Rock Resorts balances...

D.E. Shaw cut its Nio stake by 52.5% in the second quarter, while Nio reported continued strength in ES8 deliveries and raised the registered capital of its Wuhan energy subsidiary very significantly to support its battery swap and charging operations. This combination of a large institutional investor exiting and Nio doubling down on its infrastructure-heavy, partner-based battery swap model highlights a tension between investor caution and the company’s capital-intensive growth...